title: Prostate cancer screening: contrasting trends.
abstract: OBJECTIVE
  Our previously published data showed rapidly increasing rates of prostate cancer screening in men aged 50-74, which rose from 36% in 2005 to 48% in 2008. Based on men's reported intentions at that time, this was expected to rise to 70% in 2011. Here we report the actual rate of prostate cancer screening.
  
  
  METHODS
  Three nationwide observational telephone surveys (EDIFICE opinion polls) were conducted in 2005, 2008, and 2011. The overall target was a representative sample of > 1,500 individuals living in France and aged 40-75 years, including 481 men aged 50-74 years.
  
  
  RESULTS
  Within this male population, the rate of screening reported remained stable between 2008 and 2011 (48 and 49%, respectively). However, comparison of privileged versus disadvantaged populations showed significant differences, with a relative decrease in screening among those of higher socioprofessional status (p = 0.03) and from higher-income groups (p = 0.02). For households with a monthly income above 2,500€, the screening rate decreased from 61% in 2008 to 51% in 2011 (p = 0.05), while for those with an income below 2,500€, it increased from 36% in 2008 to 44 % in 2011 (p = 0.18).
  
  
  CONCLUSIONS
  A plateau or even a reduction in prostate cancer screening is currently being observed; this is possibly due to progressive recognition among the population at large of the controversy surrounding prostate cancer screening, whereas this speculation was formerly limited to health-care professionals. After previously being more likely to undergo prostate cancer screening, it is the younger, wealthier populations that are currently showing the most noteworthy step backwards.
authors.affiliation: Paoli-Calmettes Institute, UMR_S912, Marseille, France, eisingerf@ipc.unicancer.fr.
authors.forename: F
authors.initials: F
authors.lastname: Eisinger
authors.forename: J F
authors.initials: JF
authors.lastname: Morère
authors.forename: C
authors.initials: C
authors.lastname: Touboul
authors.forename: X
authors.initials: X
authors.lastname: Pivot
authors.forename: Y
authors.initials: Y
authors.lastname: Coscas
authors.forename: J Y
authors.initials: JY
authors.lastname: Blay
authors.forename: C
authors.initials: C
authors.lastname: Lhomel
authors.forename: J
authors.initials: J
authors.lastname: Viguier
mesh_terms: D000328:Adult; D000368:Aged; D055088:Early Detection of Cancer / Q000639:trends*; D005602:France; D006801:Humans; D007182:Income; D008297:Male; D008403:Mass Screening / Q000639:trends*; D008875:Middle Aged; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000175:diagnosis*
chemical_list: D017430:Prostate-Specific Antigen